Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    23911183 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Outpatient Study to Evaluate Safety and Effectiveness of the Low Glucose Suspend Feature
Condition: Type 1 Diabetes
Interventions: Device: Medtronic MMT-754 Veo Insulin pump testing Low Glucose Suspend (LGS) feature;   Device: Medtronic (NO LGS FEATURE ) using Paradigm® Revel™2.0 Pump

Indicates status has not been verified in more than two years